No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CRH240719P80000
- 1.40
- 0.000.00%
15min DelayClose Jul 12 15:59 ET
1.40High1.35Low
1.35Open1.40Pre Close15 Volume178 Open Interest80.00Strike Price2.04KTurnover21.66%IV1.03%PremiumJul 19, 2024Expiry Date0.58Intrinsic Value100Multiplier6DDays to Expiry0.82Extrinsic Value100Contract SizeAmericanOptions Type-0.5838Delta0.1716Gamma66.18Leverage Ratio-0.0654Theta-0.0072Rho-38.64Eff Leverage0.0413Vega
Intraday
- 5D
- Daily
News
Here's How Much You Would Have Made Owning CRH Stock In The Last 5 Years
CRH (NYSE:CRH) has outperformed the market over the past 5 years by 6.5% on an annualized basis producing an average annual return of 19.81%. Currently, CRH has a market capitalization of $54.37
Express News | Shares of Companies Within the Broader Materials Sector Are Trading Higher Following Recent CPI Data
CRH Is Maintained at Buy by Citigroup
CRH Is Maintained at Buy by
CRH Price Target Cut to $99.00/Share From $109.00 by Citigroup
CRH Price Target Cut to $99.00/Share From $109.00 by
Citigroup Maintains Buy on CRH, Lowers Price Target to $99
Citigroup analyst Anthony Pettinari maintains CRH (NYSE:CRH) with a Buy and lowers the price target from $109 to $99.
Is There Now An Opportunity In CRH Plc (NYSE:CRH)?
CRH plc (NYSE:CRH) saw significant share price movement during recent months on the NYSE, rising to highs of US$86.40 and falling to the lows of US$72.05. Some share price movements can give
Comments
G'day, mooers! Check out the latest news on today's stock market!
• US major indexs fell
• ASX 200 rises by broad buying; ANZ sells stake in Malaysian bank
• Stocks to watch: Telix Pharmaceuticals, Adbri, Pro Medicus
Wall Street Summary
Indexs fell Thursday after harsh earnings reactions. Overall, there was more green than red out there, but by the numbers after the close, the $S&P 500 Index(.SPX.US$ traded -0.60%,...
• US major indexs fell
• ASX 200 rises by broad buying; ANZ sells stake in Malaysian bank
• Stocks to watch: Telix Pharmaceuticals, Adbri, Pro Medicus
Wall Street Summary
Indexs fell Thursday after harsh earnings reactions. Overall, there was more green than red out there, but by the numbers after the close, the $S&P 500 Index(.SPX.US$ traded -0.60%,...
2
CRH's dividend is seen as sustainable, backed by profit and cash flow. Its growing earnings and low payout ratios hint at a promising long-term dividend stock. The firm's consistent dividend and earnings growth show a commitment to rewarding shareholders.
1
Despite lower than expected Q4 numbers, investors are not worried due to the company's positive outlook for 2024, driven by significant infrastructure investment and re-industrialization activity across key markets in North America and Europe.
The strong EPS growth and insider buying at CRH indicate a positive outlook for the company. The growth rate and insider activity suggest that the company could be a good investment opportunity.
1
The market's view of CRH has improved over the last five years, likely due to consistent earnings growth. Recent insider buying and strong share price momentum suggest potential investment opportunities.
Read more